NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Glooko

Glooko

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://glooko.com/

Last Round

Series F

Oct 10, 2024

Est. Valuation

$420.88M

Total Funding Raised

$201M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Glooko is a healthtech company that provides a remote patient-monitoring and diabetes management platform designed to integrate data from diabetes devices and fitness wearables to provide actionable insights for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Health IoT, Healthcare Analytics, Medical Devices, Patient Engagement

Business Model

B2B2C

Customer Profile

Subscription SaaS, Data as a Service, Revenue Share, Hardware Sales

AI Layer

Application

Keywords

diabetes managementremote patient monitoringRPMglucose managementconnected careclinical decision supportCDSdigital healthinpatient glucose managementEHR integrationpopulation healthmedtech softwareinsulin dosingdigital diabetesdiabetes techclinical analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Glooko Comparables

Compare Glooko with similar companies based on industry and business-model similarity.

Glooko comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tidepool
78%
Glytec
77%
Welldoc
76%

Glooko Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series FOct 10, 2024
Series DMar 16, 2021
Series CJun 27, 2017
Series CSep 13, 2016
Series BMar 17, 2015
Series A Extension
Jan 8, 2014

Key People

Founding team and executive leadership

Mark Beucler

Chief Financial Officer

Executive Team

Matteo Carli

Chief Product Officer

Executive Team

Glooko Investors

Notable investors and investment history

Glooko investors
InvestorRounds
GeorgianSeries D, Series C, Series F
Lifeforce CapitalSeries A Extension
Health Catalyst Capital ManagementSeries D
Realization Capital PartnersSeries F
Social CapitalSeries B, Series C, Series A, Seed, Series A Extension
Samsung NEXT VenturesSeries C
CambrianSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Attending the 2026 AACE Annual Meeting in Las Vegas.

  • Apr 14, 2026

    Integrated digital health solution with NextGen's EHR system.

Glooko Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Glooko Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Glooko's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range237
Year Founded2010
Last FundingOct 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.